OTC : ATBPF

Antibe Therapeutics Inc. — Institutional Ownership

$0.2156 USD

$0.0 (-0.19%)

Volume
17.94K
Average Volume
9.5K
Market Capitalization
$11.43M
P/E Ratio
-0.80
Dividend Yield
0.00%
Price Target
Year High
$0.22
Year Low
$0.19
Day High
Day Low
Payout Ratio
$0.00
Current Ratio
$15.03
Institutional Ownership Summary
Institutional Ownership %

%

Investors Holding

change: 0.0 | last:
Increased Positions

change: 0.0 | last:
Reduced Positions

change: 0.0 | last:
New Positions

change: 0.0 | last:
Sold Positions

change: 0.0 | last:
Total Calls

-

Total Puts

-

Put-Call Ratio

change: 0.0 | last:
Total Invested

-

Beneficial Ownership Filings
Filing Date Reporting Person Amount Beneficially Owned % of Class
ATBPF Enterprise Value History
Annual
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2023-03-31 $0.59 52.29M $31.04M $6.76M -$ $24.29M
2022-03-31 $0.79 50.77M $40.31M $34.81M -$ $5.5M
2021-03-31 $5.09 37.25M $189.52M $71.97M $238K $117.78M
2020-03-31 $5.83 27.27M $159.08M $6.18M $2.4M $155.3M
2019-03-31 $3.02 21.49M $64.81M $5.99M $2.07M $60.89M
2018-03-31 $4.51 15.16M $68.42M $3.73M $1.54M $66.23M
2017-03-31 $0.02 9.57M $193.8K $1.5M $3.78M $2.48M
2016-03-31 $1.39 6.28M $8.73M $386.06K $3.67M $12.01M
2015-03-31 $0.76 3.69M $2.81M $397.09K -$ $2.41M
2014-03-31 $5.27 2.62M $13.79M $3.75M -$ $10.04M
Quarterly
Date Stock Price Shares Outstanding Market Cap Cash & Equivalents Total Debt Enterprise Value
2023-12-31 $0.90 52.65M $47.54M $11.34M -$ $36.2M
2023-09-30 $0.49 52.64M $25.59M $4.14M -$ $21.44M
2023-06-30 $0.46 52.63M $24.39M $8.79M -$ $15.6M
2023-03-31 $0.59 52.62M $31.24M $6.76M -$ $24.49M
2022-12-31 $0.44 52.32M $22.88M $10.53M -$ $12.36M
2022-09-30 $0.62 52.13M $32.28M $13.6M -$ $18.68M
2022-06-30 $0.61 52.11M $31.67M $18.54M -$ $13.12M
2022-03-31 $0.79 52.04M $41.31M $34.81M -$ $6.51M
2021-12-31 $0.65 51.82M $33.89M $58.59M -$ -$24.71M
2021-09-30 $1.20 51.67M $61.76M $60.48M -$ $1.28M
2021-06-30 $3.68 47.54M $175.01M $66.79M $205K $108.43M
2021-03-31 $5.09 41.4M $210.65M $71.97M $238K $138.91M